Insider Trading April 29, 2026 09:28 PM

Slide Insurance Holdings Executive Disposes of $905,942 in Common Stock

President and COO Lucas Shannon executes planned sales amid strong quarterly earnings performance.

By Priya Menon SLDE
Slide Insurance Holdings Executive Disposes of $905,942 in Common Stock
SLDE

Lucas Shannon, serving as the President and Chief Operating Officer of Slide Insurance Holdings, Inc. (NASDAQ: SLDE), has completed a series of stock transactions totaling approximately $905,942. The divestment involved 47,668 shares of common stock and was carried out over a three-day period in late April 2026. These sales were managed indirectly via Securus Risk Management, LLC, an entity under Ms. Shannon's control, following a pre-established 10b5-1 trading plan set on November 21, 2025.

Key Points

  • The transactions were executed under a pre-arranged 10b5-1 trading plan, indicating scheduled liquidity rather than immediate reactionary selling.
  • Slide Insurance Holdings demonstrates strong recent financial momentum with a significant EPS beat in Q1 2026.
  • Market activity is occurring while the stock trades below estimated fair value levels.

Slide Insurance Holdings, Inc. (NASDAQ: SLDE) has seen notable insider activity as President and Chief Operating Officer Lucas Shannon executed a multi-day sale of common stock. Between April 27 and April 29, 2026, Ms. Shannon sold a total of 47,668 shares, generating proceeds estimated at $905,942. The transaction prices for these shares fluctuated between a low of $18.60 and a high of $19.78 per share.


Transaction Breakdown

The divestment was conducted in three distinct stages according to the filing details:

  • April 27: A sale of 13,500 shares occurred at a weighted average price of $18.75 per share, with individual transaction prices ranging from $18.60 to $19.05.
  • April 28: An additional 15,251 shares were sold, averaging $18.94 per share. The pricing for this tranche ranged between $18.75 and $19.15 per share.
  • April 29: The final portion of the sale involved 18,917 shares, which were sold at a weighted average price of $19.24 per share, with individual prices falling between $18.77 and $19.78.

These transactions were executed pursuant to a 10b5-1 trading plan that had been adopted on November 21, 2025. The sales were handled indirectly through Securus Risk Management, LLC, which is controlled by Ms. Shannon.


Current Holdings and Beneficial Ownership

Following the completion of these sales, Ms. Shannon maintains a significant interest in the company. She holds 208,101 shares directly and an additional 1,323,230 shares indirectly through Securus Risk Management, LLC. Furthermore, there is extensive beneficial ownership through her spouse, though Ms. Shannon disclaims ownership of these shares except to the extent of her pecuniary interest. The spouse's holdings include:

  • 1,137,546 shares held directly;
  • 36,571,004 shares through IIM Holdings II, LLC (a figure that accounts for a sale of 481,983 shares by the spouse between April 27-29, 2026, via a separate 10b5-1 plan);
  • 1,925,000 shares through the Emma Cloonen Irrevocable Trust;
  • 1,925,000 shares through the Ava Cloonen Irrevocable Trust;
  • 2,575,837 shares through the Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014.

Financial Context and Market Position

The insider selling occurs against a backdrop of recent positive financial reporting for Slide Insurance Holdings. The company reported first-quarter 2026 earnings that exceeded analyst expectations, posting an earnings per share (EPS) of $1.02 compared to the projected $0.67, representing a surprise of 52.24%. During this same quarter, revenue reached $389.3 million.

Currently valued at $2.16 billion, Slide Insurance Holdings maintains an "EXCELLENT" financial health score and has been profitable over the preceding twelve months with earnings of $3.62 per share. While the stock was trading at $18.41 at the time of reporting, this remains below the fair value estimate of $21.32, suggesting a potential undervaluation despite the recent insider liquidations.


Key Points

  • Planned Divestment: The sales were not spontaneous but part of a 10b5-1 trading plan established in late 2025, which is a standard mechanism for executives to manage equity.
  • Strong Fundamentals: Despite the sale, the company's recent earnings beat and revenue figures indicate robust operational performance within the insurance sector.
  • Valuation Discrepancy: The current trading price of $18.41 sits below estimated fair value, highlighting a gap between market price and internal valuation metrics.

Risks and Uncertainties

  • Insider Sentiment: While the sales were pre-planned, large-scale liquidations by top executives can sometimes influence broader market sentiment regarding the stock's immediate trajectory.
  • Market Volatility: The discrepancy between current trading prices and fair value estimates introduces uncertainty for investors regarding how quickly or if the market will correct to reflect intrinsic value.

Risks

  • The volume of shares being moved by both the COO and her spouse could impact short-term liquidity and investor perception in the insurance sector.
  • Discrepancies between current market prices and perceived fair value represent a valuation risk for incoming investors.

More from Insider Trading

Marcus & Millichap Director Executes Substantial Common Stock Purchase May 4, 2026 Patterson-UTI CEO Executes Multi-Million Dollar Stock Sale Amidst Year-to-Date Surge May 4, 2026 Snowflake Director Michael Speiser Executes $7.18 Million in Stock Sales May 4, 2026 Edwards Lifesciences Executive Executes Stock Transactions Amid Recent Financial Growth May 4, 2026 Entrada Therapeutics President and COO Executes Stock Sale via Rule 10b5-1 Plan May 4, 2026